Investigations of the pathogenesis of varicella zoster virus infection in the SCIDhu mouse model

Herpes

Volumn 13, Issue 3, 2006, Pages 75-80

  Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Herpesvirus; Pathogenesis; SCIDhu mouse model; Varicella zoster virus; Xenograft

Indexed keywords

ALPHA INTERFERON; CHICKENPOX VACCINE; LIVE VACCINE;

ARTICLE; CHICKENPOX; GENE MUTATION; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; MUTAGENESIS; NEUROTROPISM; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; SCID MOUSE; SENSORY GANGLION; SKIN INFECTION; SPINAL GANGLION; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS; VIRAL GENETICS; VIRUS GENE; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS REPLICATION; XENOGRAFT;

ANIMALS; CHICKENPOX; CHICKENPOX VACCINE; DISEASE MODELS, ANIMAL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MICE; MICE, SCID; NEURONS; SKIN; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS; VACCINES, ATTENUATED;

HERPES ZOSTER; HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 33845630231     PISSN: 09697667     EISSN: 14701537     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cohen J, Straus S. Varicella-zoster virus and its replication. In: Fields Virology, 4th edn (Knipe DM, Howley P, eds). Philadelphia: Lippincott Williams & Wilkins, 2001;pp2547-2586.
2. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-645.
3. Arvin AM. Varicella-zoster virus. In: Fields Virology, 4th edn (Knipe DM, Howley P, eds). Philadelphia: Lippincott Williams & Wilkins, 2001;pp2731-2768.
4. Arvin, AM, Schaap AC, Ku C-C, Jones JO, Sommer M, Zerboni Z. Investigations of the molecular mechanisms of varicella-zoster virus pathogenesis. In: The Alphaherpesviruses (R Sandri-Golden, ed.), 2006. Norfolk UK: Caister Academic Press, 2006;pp283-304.
5. Ku CC, Besser J, Abendroth A, Grose C, Arvin AM. Varicella-zoster virus pathogenesis and immunobiology: New concepts emerging from investigations in the SCIDhu mouse model. J Virol 2005;79:2651-2658.
6. Zerboni L, Ku CC, Jones C, Zehnder J, Arvin AM. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci USA 2005;102:6490-6495.
7. Moffat JF, Stein MD, Kaneshima H, Arvin AM. Tropism of varicella-zoster virus for human CD4+ and CD8+ T-lymphocytes and epidermal cells in SCID-hu mice. J Virol 1995;89:5236-5242.
8. Ku CC, Padilla J, Grose C, Butcher EC, Arvin AM. TVopism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory and skin homing markers. J Virol 2002;76:11425-11433.
9. Ku CC, Zerboni L, Ro H, Graham B, Wallace M, Arvin A.M. Transport of varicella-zoster virus to skin by infected CD4 T cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med 2004;200:917-925.
10. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicella zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001;75:4878-888.
11. Jones JO, Arvin AM. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCID hu skin xenografts in vivo. J Virol 2003;77:1268-1280.
12. Jones JO, Arvin AM. Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 2006;80:5113-5124.
13. Moffat J, Zerbini L, Kinchington PR, Grose C, Kaneshima H, Arvin A. Attenuation of the vaccine Oka strain of varicella-zoster virus and the role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 1998;72:965-974.
14. Arvin AM. Varicella vaccine: genesis, efficacy and attenuation. Virology 2001;284:153-158.
15. Cohen JI, Seidel KE. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidine synthetase is not essential for replication in vitro. Proc Nat Acad Sci USA 1993;90:7376-7380.
16. Mallory S, Sommer M, Arvin AM. Mutational analysis of varicella-zoster virus (VZV) glycoproteins, gI and gE, in recombinant VZV strains. J Virol 1997;71:8279-8288.
17. Kemble GW, Annunziato P, Lungu O, Winter RE, Cha TA, Silverstein SJ et al. Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J Virol 2000;74:11311-11321.
18. Niizuma T, Sommer MH, Ito H, Hinchliffe S, Zerboni L, Arvin AM. Construction of varicella-zoster virus recombmants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol 2003;77:6062-6065.
19. Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S et al. Analysis of varicella-zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 2005;332:337-346.
20. Besser J, Ikoma M, Fabel K, Sommer MH, Zerboni L, Grose C et al. Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection of skin and T cells. J Virol 2004;78:13293-13305.
21. Moffat J, Sommer M, Taylor S, Mallory S, Arvin AM. VZV glycoprotein I is required for viral replication in skin and T cells. J Virol 2002;76:8468-S471.
22. Cole NL, Grose C. Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella zoster virus. Rev Med Virol 2003;13:207-222.
23. Moffat J, Cheng JJ, Sommer M, Mo C, Zerboni L, Stamatis S et al. Functions of the C-terminal domain of varicella-zoster virus glycoprotem E in viral replication in vitro and skin and T cell tropism in vitro. J Virol 2004;78:12406-12415.
24. Santos RA, Hatfield CC, Faga BP, Padilla JA, Cole NL, Moffat JF et al. Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 2000;275:306-317.
25. Schaap A, Fortin JF, Sommer M, Zerboni L, Stamatis S, Ku CC et al. T cell tropism and the role of ORF66 protein in the pathogenesis of varicella-zoster virus infection. J Virol 2005;79:12921-12933.
26. Schaap Nutt A, Sommer M, Che X, Zerboni L, Arvin AM. ORF66 protein kinase function is required for T cell tropism of varicella zoster virus in vivo. J Virol 2006 Sep 13 (Epub ahead of print 13 September 2006).
27. Besser J, Sommer MH, Zerboni L, Bagowski C, Ito H, Moffat J et al. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J Virol 2003;77:5964-5974.
28. Ito H, Sommer MH, Zerboni L, He H, Hay J, Ruyechan W et al. Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transcription factors, Sp1 and USF determine virulence for human skin and T cells in the SCID hu mouse in vivo. J Virol 2003;77:489-498.
29. Che X, Zerboni L, Sommer MH, Arvin AM. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T-cells in vivo. J Virol 2006;80:3238-3248.
30. Sato B, Ito H, Hinchliffe S, Sommer MH, Zerboni L, Arvin AM. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J Virol 2003;77:5607-5620.
31. Baiker A, Fabel K, Cozzio A, Zerboni L, Fabel K, Sommer M et al. Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci USA 2004;101:10792-10797.